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ABSTRACT
Background: Chronic hookworm infection affects an estimated 576 to 740 million people
worldwide. Despite mass drug administration efforts, the morbidity associated with this soiltransmitted helminth remains a significant public health issue. Due to inter- and intracommunity heterogeneity in susceptibility to infection, mathematical modeling can serve as an
effective and efficient tool for investigating hookworm transmission in different settings and for
guiding policymakers to consider new treatment and prevention strategies.
Methods: Here we developed an age-structured, compartmental S-I model to identify
epidemiological parameters for hookworm infection and to assess rates of attributable anemia
within the population of Zanzibar. The model was first used to address the relative contributions
of age group (adults versus children) and infection intensity status (high versus low) in
transmission. The Markov chain Monte Carlo (MCMC) method was implemented to generate
negative binomial distribution parameters for describing population-level parasite aggregation.
Gibbs sampling and data on prevalence of hookworm infection were used in a subsequent
MCMC to parameterize the overall model and account for uncertainty. Maximum likelihood
point estimates for force of infection and natural recovery were derived from the 10,000
posterior distributions generated. Empirical data on average hemoglobin levels for given fecal
egg count categories were included in the analysis to give distributions for the relative risk of
moderate-to-severe anemia (hemoglobin < 90 g/L) among infected versus susceptible
individuals.
Results: Using maximum likelihood estimates for the negative binomial distribution parameters,
it was determined that children prone to high intensity hookworm infections were 4.9 times as
infectious as children prone to lower intensity infection; high intensity infection adults were
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considered to be 4.7 times as infectious as low intensity infection adults. Model predictions with
and without uncertainty were consistent in estimating that approximately 10% of the infected
child population experienced moderate-to-severe anemia attributable to hookworm infection.
Conclusion: The present model provides a population-level compartmental model framework
for assessing hookworm-attributable morbidity independent of assumptions about worm burden
thresholds. To evaluate the effectiveness of different intervention strategies at reducing the
incidence of infection and rates of hookworm-attributable anemia, the current epidemiological
model can be extended structurally to include treatment and vaccine parameters.
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INTRODUCTION
Background
Affecting an estimated 576-740 million people worldwide, human hookworm infection
contributes significantly to the global incidence of iron-deficiency anemia, protein malnutrition,
and other comorbid conditions [1-3]. In fact, chronic hookworm infection accounts for nearly
22.1 million of the 57 million DALYS associated with all neglected tropical diseases [1]. Most
human infections are attributed to two hookworm species, Necator americanus and Ancylostoma
duodenale, which are endemic in tropical and subtropical regions of sub-Saharan Africa, south
China, Southeast Asia, and the Americas [4]. The climate in these regions is conducive to larval
survival, and in less developed regions, poor nutritional status combined with lacking sanitation
infrastructure provides for significant morbidity due to high transmission rates and chronic
infection [5].
Hookworm infection results as third-stage larvae (L3) penetrate exposed skin upon
contact with contaminated soil. The larvae enter the circulatory system and migrate to the lungs.
After coughing expels them from the respiratory tract, the parasites are swallowed into the
digestive system and form a buccal capsule equipped with cutting plates [6, 7].

Larvae

ultimately mature into adult hookworms in the small intestine, where their feeding on the mucosa
and submucosa leads to a daily loss of up to 9 ml of blood [8]. While in the intestine, adult
hookworms reproduce and their eggs are excreted with fecal matter [9]. Low iron bioavailability
in hookworm-endemic regions increases susceptibility to iron deficiency anemia due to diets
heavily dependent on starch-based foods, such as cassava [10].

Current and Projected Control Measures
Over the past several decades, widespread deworming efforts targeting high-risk
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individuals have been undertaken to reduce the prevalence and intensity of STH infection [11].
Such programs have involved the administration of single-doses of benzimidazoles, such as
mebendazole (500 mg dose) and albendazole (400 mg dose), in schools and other community
settings [12]. In 2001, the World Health Assembly established a goal of treating 75% of all atrisk school-aged children with anthelminthics by 2010 [13]. However, it is projected that longterm mass treatment using benzimidazoles will be increasingly less effective due to rapid rates of
reinfection and the likely emergence of drug resistance [14-16]. In addition, individual- and
community-level differences in benzimidazole efficacy have been demonstrated [11], with a
recent meta-analysis of randomized placebo-controlled studies reporting cure rates for singledose oral albendazole (400 mg) as low as 40% in Kenya (n = 34) during 1999 to as high as 100%
in Haiti (n = 12) during 1990 [17].
In response to limited treatment options and variable efficacy, efforts are currently
underway to identify antigens for development of a human hookworm vaccine. The current
approach involves investigation into a bivalent vaccine that will affect both the larval and adult
stages of the parasite’s life cycle [4]. One potential class of antigens includes the aspartic
proteases (APRs), which are proteolytic enzymes that interfere with the parasite’s digestion of
skin macromolecules and thus inhibit larval movement across the epithelial barrier and into the
circulatory system [7, 8].

Another class, the Ancyclostoma secreted proteins (ASPs), are

involved in maturation of L3 larvae to adult hookworms upon human serum stimulation [8].
Table 1 outlines recently investigated vaccine targets and the current phase of development for
each.
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Study Target Population
The island region of Zanzibar is located off the coast of Tanzania. In 1994, a schoolbased deworming program was launched by the local Ministry of Health and Social Welfare and
involved administration of single does of mebendazole two to three times per year on Pemba, the
smaller of the two islands making up Zanzibar [18]. The program was eventually extended to all
of Zanzibar with reported coverage rates as high as 90% of all primary school children [19]. The
school-based program was disrupted in 2000 due to difficulties in securing sufficient
anthelmintic drugs.

It was restarted in 2003 with the administration of albendazole and

praziquantel [20]. In 2001, Zanzibar also launched a community-wide campaign, The Global
Elimination of Lymphatic Filariasis (GELF), which involved annual administration of
albendazole and ivermectin to all eligible adults and children. The combined effect of GELF and
school-based deworming programs on helminth infection has been investigated [21]. The safety
of combining community-based programs to address STH and other endemic parasitic infections
has been considered as well [22]. Despite decades of large-scale deworming programs, infection
prevalence remains as high as 99% in regions of the islands and some degree of iron deficiency
anemia has been found to afflict about 60% of children [18, 19]. Due to extensive evaluation of
the impact of mass drug administration in Zanzibar, trends in hookworm prevalence and disease
intensity have been well documented. The region would thus be a feasible and logical site for
future effectiveness trials on vaccination and other intervention strategies.

Existing Models
Mathematical modeling offers an effective and efficient way of evaluating hookworm
transmission dynamics and considering how new intervention strategies could impact rates of
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morbidity.

Since the 1980’s, models on helminth infection have evolved to include new

approaches to treatment, prevention, and control. Anderson and May proposed an early wormbased model for evaluating the basic reproductive rate (R0) for macroparasites and considering
the impact of treatment in terms of changing the mean worm burden and reducing R0 to below
unity [23]. Medley et al expanded upon this model to specifically investigate the effect of
anthelminthic treatment on symptoms attributable to roundworm (Ascaris lumbridoides)
infection [24]. The use of a worm burden threshold to model levels of morbidity was further
extended by Chan and his colleagues who incorporated age structuring into the Anderson and
May model and compared predictions when different mechanisms of population-level host
mixing were considered [25]. Most recently, Sabatelli et al developed an individual-based model
to consider the impact of human hookworm vaccination in the context of community-level
parasite aggregation and variation in host susceptibility [5].
Despite significant progress in the development of mathematical models for helminth
infections over the last several decades, the Disease Reference Group on Helminth Infections
(DRG4), established by the Special Programme for Research and Training in Tropical Diseases
(TDR), recently issued an agenda highlighting research priorities and gaps to address when
modeling helminth infections [26]. Notably, it was recommended that models should be refined
to more accurately capture the relationship between morbidity and the evolving infection status
of individuals in regions with intermittent treatment and control campaigns [26].

Study Objectives
Here we construct and parameterize an age-structured, risk-stratified deterministic model
to identify epidemiological parameters for hookworm infection and attributable morbidity within
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the population of Zanzibar. For the present model, morbidity was defined as anemia with a
hemoglobin level less than 90 g/L. An expanded model representing treatment and vaccination
is also presented but not parameterized. As far as we know, this is the first population-based
deterministic model for evaluating the epidemiological impact of human hookworm infection.
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METHODS
Description of Compartmental Model
A deterministic model was constructed to evaluate the population-level transmission
dynamics of human hookworm infection and estimate moderate-to-severe anemia among
infected children in Zanzibar. This age-structured model (Figure 1) includes child compartments
(subscript C) representing individuals younger than 15 years old and adult compartments
(subscript A) representing individuals 15 years and older. The age cutoff was chosen since
treatment programs in Zanzibar target school-age children and the model was developed for
ultimate use in evaluating similarly targeted intervention strategies. To reflect community-level
overdispersion of hookworm burden, both age classes were subdivided with individuals prone to
high intensity infection (subscript 20) distinguished from those prone to low intensity infection
(subscript 80).

Individuals in the high intensity compartments are expected to be more

susceptible to infection due to nutritional, behavioral, and genetic factors as well as past infection
experiences [23, 27]. The negative binomial distribution is frequently used when modeling
parasite aggregation, and within high aggregation communities, it is often found that 20% of a
given population harbors over 80% of the burden [28] such that for the present model, both age
classes were risk-stratified to distinguish between those prone to heavy (20% of population)
versus light (80% of population) intensity infections. The overall S-I model structure assumed
underlying levels of anemia due to nutritional and other factors. Moderate-to-severe anemia was
defined in terms of hemoglobin levels less than 90 g/L. This cut off is consistent with that
previously used during trials to investigate the effectiveness of hookworm control measures in
Zanzibar [10]. Children and adults transition from the S compartments to I compartments at a
rate defined by the force of infection γ, given by the following equation:
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(1)

All infected individuals are assumed to acquire hookworms through contact with
contaminated soil and have a chance of natural recovery back to the S compartment at a rate, ρ.
The movement of individuals between compartments is given by eight (8) ordinary differential
equations.
!!!!"
!"
!!!!"
!"
!!!!"
!"
!!!!"
!"
!!!!"
!"
!!!!"
!"
!!!!"
!"
!!!!"
!"

= !!" ! − !! !!!" − !!!!" − !!!!" + !!!!"

(2)

= !!" ! − !! !!!" − !!!!" − !!!!" + !!!!"

(3)

= !!!!" − !! !!!" − !!!!" − !!!!"

(4)

= !!!!" − !! !!!" − !!!!" − !!!!"
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(9)

Parameterization and Uncertainty Analysis
Demographic and disease parameters were used to define the transitions into and out of
compartments. All parameters for the transmission-only model are defined in Table 4.
(a) Demographic Parameters
Census data were used to identify and calibrate point estimates for birth rate, child- and
adult-specific death rates, and the rate of aging from child to adult compartments. Calibration
involved setting the birth rate equal to the estimate derived from census data and adjusting the
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death and aging rates to achieve both empirical population-level growth rates and age
structuring, respectively [29].
(b) Force of Infection Equation
According to our model, the force of infection addresses two between-compartment
relationships for the infectiousness of different groups of individuals.
The first relationship involves the relative infectiousness of individuals in high versus
low infection intensity compartments. This relationship was quantified as a multiplicative factor
relating β80 and β20 and was calculated as a ratio of the expectation of the lower 80 percent of the
density function for population-level fecal egg counts and the expectation of the upper 20 percent
of the same density function. Egg counts were used as an indicator of infectiousness since
excreted hookworm eggs contaminate soil in areas lacking developed sanitation systems and
subsequently result in the development of infectious L3 hookworm larvae [6].

A binned

negative binomial distribution and a flat prior were used to model the probability of a given egg
count in eggs per gram (epg) of fecal sample. Posterior distributions for mean and variance
parameters of a negative binomial distribution were generated through the Markov chain Monte
Carlo (MCMC) method. Although the likelihoods of ! and ! ! estimates were considered in the
MCMC, equations ! =   

!!

!!

1−

!

and ! =   

!!

!

,
!!

where ! ! = ! +

!!

!, were

utilized to produce distributions for the number of successes (R) and probability of success (P)
parameters specific to the calculation of the negative binomial cumulative distribution function
in Matlab.

A single MCMC was conducted for children and adults since independence of the

study populations could not be assumed; however, separate ! and ! ! parameters of the negative
binomial distribution were evaluated for each of the two age classes. The likelihood function
(Equation 10) for this analysis was based on population-level data that classified individuals into
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four categories of hookworm infection intensity based on fecal egg counts [10]. The function
depends on !! = ! ! − !(!), or an individual’s probability of being in a given fecal egg count
category (range: z epg – y epg), as determined by the negative binomial cumulative distribution
function; !!" and !!" represent the number of children and adults, respectively, from the study
sample in the ith non-zero fecal egg count category.
ℓ !! , !!! , !! , !!! =

!
!!! !!"

∗ log  (!!" ) +

!
!!! !!"

∗ log  (!!" )  

(10)

Best-fit estimates for the four parameters were considered as those that maximized the
log likelihood equation in 200,150 iterations, with an expected burn-in period of 150 iterations.
The negative binomial distributions generated by the best-fit parameters resulting from this
MCMC were used to determine the expected egg count of an individual in the lower 80% of the
density function and the expected egg count of an individual in the upper 20% of the density
function, and a ratio was taken. To address the uncertainty in the estimates, the entire parameter
distributions from the MCMC were used to produce vectors of ratios to be applied as a prior
distribution for the multiplicative factor relating βC80 and βC20 or that relating βA80 and βA20 in the
uncertainty analysis.
The second relationship within the force of infection equation considered the relative
infectiousness of adults versus children.

Unlike parasite burden of other soil-transmitted

helminth infections which peaks during adolescence and subsequently declines, the mean
number of hookworms per person increases gradually until plateauing during adulthood [6].
However, considerable between-community heterogeneity has been observed in the relative
infectiousness of adults versus children [25, 30]. In accord with the findings of Chan et al [25]
for a comparable sub-Saharan African community, it was assumed for the present analysis that
Zanzibari children are twice as infectious as adults due to less hygienic practices and a higher
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basic reproductive rate of worms; however, other relationships were considered in the
uncertainty analysis.
(c) Disease Parameters
Point estimates for baseline prevalence of hookworm infection for children and adults in
Zanzibar were extracted from the available literature (Table 1). Prevalence estimates were
assumed to follow the binomial distribution and be independent of one another. The MCMC
method was used to determine the values of βC80 and ρ that maximized a log likelihood function
based on the experimental prevalence data (Equation 11). The beta-binomial distribution was
assumed for the prevalence estimates. In the equation, !! represents the prevalence estimate for
children derived from a cross-sectional study by Stoltzfus et al [31] on Pemba Island, Zanzibar
prior to mass drug administration and !! represents a prevalence estimate for Zanzabari adults
[32], while !!! and !!! represent the prevalence levels predicted with a given set of parameter
estimates.
ℓ !!!" , ! = !! !! ∗ log !!! + !! − !! !! ∗ log 1 − !!!
+  !! !! ∗ log !!! + !! − !! !! ∗ log 1 − !!!   

(11)

Uninformative flat prior distributions were assumed for the two disease parameters. For the
uncertainty analysis, iterative Gibbs sampling was used to draw from the posterior distributions
for the multiplicative factors relating βC80 and βC20 or that relating βA80 and βA20 to parameterize
the force of infection equation.
(d) Age Class Multiplier
Significant inter-community heterogeneity in the relative infectiousness of adults and
children has been documented by Chan et al [25, 30]. For the present paper, it was assumed that
children in Zanzibar are more infectious due to behavioral factors. However, to address the
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possibility of other relationships, the age-class multiplier was added as an additional parameter in
the MCMC and allowed to vary randomly to consider the possible scenarios of increased
infectiousness among adults and equal infectiousness between adults and children; the trend of
the resulting MCMC output was visually inspected for convergence.
(e) MCMC Convergence Diagnostic
The MCMC process was repeated to generate a series of two chains for each parameter; a
burn-in period of 150 iterations of overdispersed values was used. Convergence of posterior
distributions was tested using the Gelman-Rubin diagnostic [33, 34]. This diagnostic uses the
potential scale reduction factor (!), involving the estimated variance of a given parameter based
on both the within- and between-chain variances, to determine whether the parameter
distributions generated through the MCMC process converge to a stationary distribution
(Criterion: ! < 1.2). ! was calculated and the plot reflecting change in Gelman and Rubin's
shrink factor was evaluated for each parameter [33].

Morbidity Measures
Using published data on hemoglobin levels for a sample of Zanzibari children
categorized according to five fecal egg count bins [31], the proportions of the susceptible (0 eggs
per gram feces) and infected (>0 eggs per gram feces) populations with anemia were calculated.
For individuals within a given fecal egg count range, hemoglobin (Hb) measurements were
assumed to follow a normal distribution. Underlying levels of anemia due to nutritional status,
malaria, and other factors were also assumed. The proportion of individuals with anemia not
attributable to hookworm infection was found as the density of the cumulative distribution
function below 90 g/L Hb for uninfected individuals. A point estimate for the proportion of
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susceptible children with anemia was calculated using the mean and standard deviation for
hemoglobin levels among individuals in the 0 eggs per gram feces category. For each fecal egg
count category (i) of infected individuals, the density of the normal cumulative distribution
function (A) under 90 g/L was multiplied by the proportion of the population with egg counts in
that range (z epg – y epg), as determined using the best-fit parameters of the negative binomial
distribution (F) found in the first MCMC (Equation 12).
!"#$#"%&#'  !"#ℎ  !"#$%& =   

!
!!!

!! 90 − !! (0) ∗ ! !! − !(!! )

(12)

For both susceptible and infected individuals, the uncertainty in the empirical data was
addressed by drawing 10,000 random numbers from a normal distribution with the published
mean and standard deviation for each fecal egg count range and randomly selecting a new mean
for the distribution of anemia. Additionally, Gibbs sampling was used to select mean and
variance estimates generated in the first MCMC for parameterizing the negative binomial
distribution in the uncertainty analysis.
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RESULTS
Data
Data on prevalence of hookworm infection in adult and child populations from Zanzibar
or representative areas of eastern Tanzania were extracted from the available literature. Pretreatment estimates for prevalence of hookworm infection were found for children and adults
(Table 2). The number of individuals in the high intensity compartments was calculated as the
20% of the population expected to harbor the majority of the hookworm burden [6, 23].

MCMC Convergence
The Markov chain Monte Carlo (MCMC) method was used to generate posterior
distributions for mean and variance parameters of negative binomial distributions describing
fecal egg counts in child and adult populations. The Gelman-Rubin diagnostic (!) was found to
be between 1.0 and 1.04 upon comparing two chains of parameter values for each of the four
parameters considered in the MCMC. A similar analysis of convergence was conducted to
evaluate the chains of posterior distributions of the two disease transmission parameters (!!!"
and !) generated through the second MCMC. Figure 2 reflects the tendency toward stationary
distributions for the disease parameters based on the evolution of Gelman and Rubin's shrink
factor.
When the age-class multiplier was allowed to vary to explore other possible relationships
in the relative infectiousness of adults versus children, no convergence for this parameter was
observed. As a result, the relationship was fixed with children being twice as infectious as adults
(!!!" = !! ∗    !!!" ) for the remaining analyses.
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Model Predictions Using Point Estimates
Best-fit point estimates were determined as values maximizing the log likelihood
functions for parameterizing the negative binomial distribution and subsequently the
transmission model. All parameter estimates are presented in Tables 3 and 4. It was found that
children in the model had, on average, 1303 hookworm eggs per gram feces and that, on average,
adults had 1622 hookworm eggs per gram feces. Children prone to high intensity infections were
found to be 4.9 times more infectious as children prone to low intensity infections in terms of
their relative fecal egg counts. Adults prone to high intensity infections were similarly found to
be 4.7 times more infectious as adults prone to low intensity infections. Using this information
to parameterize the force of infection equation and run the transmission model, it was determined
that moderate-to-severe anemia affected 6.2% of susceptible children. Among infected children,
16.4% were found to have hemoglobin levels less than 90 g/L. Accordingly, the model predicted
the prevalence of hookworm-attributable anemia among children to be 10.2%.

Model Predictions with Uncertainty
The Markov chain Monte Carlo process was implemented twice to account for
uncertainty in the data used. The first MCMC considered the distributions of fecal egg counts
for adults and children. A jump size of 250 (acceptance ratio: 0.5296) and a jump size of 0.32
(acceptance ratio: 0.5834) were used for !! and !!! , respectively.

A jump size of 445

(acceptance ratio: 0.5122) and a jump size of 0.40 (acceptance ratio: 0.6334) were used for !!
and !!! , respectively. The resulting distributions of likely means and variances for the negative
binomial distribution were used to find either the risk-class multiplier relating βC80 and βC20 or
that relating βA80 and βA20 (Figures 3 and 4). When taking uncertainty into account, it was found
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that the relative infectiousness of children in the high intensity infection compartment compared
to that of children in the low intensity infection compartment ranged between 3.4 and 7.2. The
infectiousness of the adults in the high intensity infection compartment was found to be between
2.8 and 12.2 times that of adults in the low intensity infection compartment.

Ranges of

parameter estimates from the uncertainty analysis are presented in Table 3. The second MCMC
used Gibbs sampling to evaluate the force of infection equation and prevalence data to
parameterize the overall transmission model. A jump size of 0.0025 (acceptance ratio: 0.2699)
and a jump size of 0.0001 (acceptance ratio: 0.3115) were used for !!!" and !, respectively. It
was determined that underlying levels of anemia affect between 0% and 99.7% of the modeled
child population (! = 14.2%). Among the infected children compartments, it was found that
between 0% and 93.1% had hemoglobin levels less than 90 g/L (! = 24.1%). Figures 5 and 6
are histograms representing the frequencies of proportions for moderate-to-severe anemia in
susceptible and infected child populations, respectively. Accordingly, when accounting for
uncertainty, the model predicted rates of childhood anemia attributable to hookworm infection is,
on average, 9.9%.
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DISCUSSION
Results and Implications
Chronic hookworm infection is a leading but preventable cause of anemia and other
morbidity throughout communities that lack access to sufficient hygiene and sanitation
resources. Despite efforts at mass drug administration, the global prevalence of hookworm
infection remains high and post-treatment rebounding suggests that current measures are not
sustainable [16]. Mathematical modeling offers an effective tool for considering populationlevel transmission dynamics and provides the framework for evaluating the impact of future
interventions against hookworm infection. The present model is unique in that it is the first
population-level compartmental model for human hookworm infection and that it does not
depend on a worm burden threshold for determining levels of morbidity. Worm- and individualbased models have considered a wide range (40-160 worms) as the threshold for morbidity and
extrapolating worm burden from fecal egg counts is variable and often unreliable [35, 36].
Using empirical distributional data for hemoglobin levels and well-established trends in parasite
aggregation, we were able to determine the proportion of children with underlying anemia versus
anemia attributable to hookworm infection both with and without model uncertainty.

Limitations
The present findings are limited by assumptions about the population-level distribution of
hookworm infection. In particular, risk stratification in the current model depends on the “80-20
Rule” which accounts for both parasite aggregation and the observed tendency of a small
proportion of the population having increased susceptibility to higher intensity infections.
Specifically, according to this rule, it is expected that 20% of the population in a given
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community harbors over 80% of the total worm burden [23]. The degree of parasite aggregation
that corresponded with the data used to generate negative binomial distributions in the present
study was considered in an a posteriori analysis. Gibbs sampling was performed to randomly
select a mean/variance pair for children or adults and parameterize a negative binomial
distribution.

Using the resulting distributions, 3213 and 1077 observations were randomly

generated to represent the worm burdens for samples comparable in size to the original
experimental samples of children and adults, respectively [31, 32].

For the distribution

representing each age class, all observations were sorted and normalized by their sum. Upon
sorting, the observation representing the cutoff between the lower 80% of observed egg counts
and the upper 20% of observed egg counts was determined. This process was repeated for 5000
iterations. The mean density above the 80% cutoff (the 2571st observation for children and the
862nd observation for adults) was found to be 70.09% for children and 71.11% for adults.
The current model uses the 80-20 cutoff as a way of subgrouping the population
according to risk level, so the fact that the empirical distribution does not follow the 80-20
expectation does not immediately impact the findings. However, despite wide use of this rule for
risk stratification, an empirically supported approach to categorizing by host susceptibility and
parasite aggregation should be investigated and the impact of this particular cutoff on our
transmission model should be considered in a sensitivity analysis.

Future Directions
The transmission model was expanded structurally to account for treatment and
vaccination against hookworm infection (Figure 7). The intervention parameters and variables
are described in Table 6. Before implementation of the full intervention model, it will be
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important to consider how treatment and vaccination efficacy will be measured.

Efficacy

measured as the transition from infected to susceptible is expected to be an overly conservative
approach since reduction in infection intensity without complete cure is sufficient to reduce
morbidity. That is, anemia and other comorbidities are more prevalent among individuals with
high intensity infections [6]. To capture this in the S-I compartmental framework, we will
evaluate shifts in the negative binomial distribution—widely accepted to reflect parasite
aggregation and individual-level susceptibility to hookworm infection [23]. It is expected that a
compartmental model which stochastically models individual predisposition to infection, parasite
aggregation in the host population, and parasite density dependence will sufficiently capture this
distributional change at the population level without the computational requirements of an
individual-based model.

Treatment and vaccine efficacies will be modeled as binomial

probabilities of an individual hookworm’s death due to intervention. This approach was used by
Sabatelli et al in modeling the impact of anthelminthic treatment [5]. Reinfection studies are
expected to provide insight into the distributional nature of levels of susceptibility and the
sensitivity of the model to risk stratification, as individuals with high intensity infection are more
likely to return to the same infection intensity status after treatment effects wane.

Conclusion
In summary, despite the limited availability of empirical data, an uncertainty analysis of
our hookworm model provides insight into population-level transmission dynamics and allows
for estimation of directly unmeasurable quantities such as relative infectiousness and parasite
aggregation. Underlying trends in infection were evaluated in terms of age-class and risk-class
multipliers and rates of moderate-to-severe anemia among both susceptible and infected child
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compartments were determined using distributional data on hemoglobin levels across fecal egg
count categories instead of relying on a worm burden threshold. In addition, the structural
framework for a compartmental model accounting for treatment and prophylactic measures was
provided and recommendations were offered for parameterization and interpretation.
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FIGURES AND TABLES
FIGURE 1: Model of Human Hookworm Transmission
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FIGURE 2: Demonstration of Markov chain Monte Carlo (MCMC) Convergence

Figure 2a. Gelman and Rubin shrink factor for !!!"

Figure 2b. Gelman and Rubin shrink factor for !
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FIGURE 3: Histogram of Multiplier Relating !!!" and !!!" for Mean Egg Count of High
Intensity Versus Low Intensity Infection Adults

FIGURE 4: Histogram of Multiplier Relating !!!" and !!!"   for Mean Egg Count of High
Intensity Versus Low Intensity Infection Children
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FIGURE 5. Histogram for the Proportion of the Susceptible Child Population with Moderate-toSevere Anemia

FIGURE 6. Histogram for the Proportion of the Infected Child Population with Moderate-toSevere Anemia
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FIGURE 7. Full Epidemiological Model with Treatment and Vaccination Parameters (without
risk stratification)
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TABLE 1. Human Hookworm Vaccine Targets
Target
Necator americanus
Ancyclostoma-secreted
protein 2 (Na-ASP-2)
Glutathione S-transferase
(Na-GST-1)

Vaccine Mechanism
Attenuate L3 larval migration to the
gastrointestinal tract; generate antibodies to
decrease risk of hookworm disease due to heavy
infections [37]
Interfere with the digestive proteolytic cascade that
is responsible for heme detoxification [4]

Necator americanus aspartic
protease
(Na-APR-1)

Target macromolecules required by the mature
parasite to metabolize erythrocytes; particularly,
interfere with hemoglobin proteolysis [7]

Stage in Vaccine Development
Phase I clinical trial suspended in
2007 due to safety concerns
regarding reports of allergic
reactions [38]
Part 2 of a Phase I clinical trial
currently underway among adults
in Brazil [39]
Phase 1 study of safety and
immunogenicity scheduled to
begin in Washington, DC in June
2013 [40]

TABLE 2: Pre-Treatment Prevalence of Hookworm Infection
Compartment
Infected, Asymptomatic
Children
Infected Adults

Symbol
Ic
Ia

Measure

Prevalence Estimate

Reference

Prevalence of Hookworm Infection
among Children (epg > 0)
Prevalence of Hookworm Infection
among Adults (epg > 0)

72.5%

[31]

92.8%

[32]

TABLE 3: Descriptions and Estimates for Parameterization of the Negative Binomial Distribution
Model parameter definition
Mean fecal egg count for
children (eggs per gram
feces)
Aggregation parameter for
children
Mean fecal egg count for
adults (eggs per gram feces)
Aggregation Parameter
(Adults)
Egg count cutoff between
risk stratification categories
for children (eggs per gram
feces)
Egg count cutoff between
risk stratification categories
for adults (eggs per gram
feces)
Ratio of relative
infectiousness between
children prone to high versus
low intensity infection
Ratio of relative
infectiousness between
adults prone to high versus
low intensity infection

	
  

Symbol

Best Fit Point Estimate

Range

!!

1303.3

1044.6-1691.0

!!

0.8485

0.5196-1.5175

!!

1621.6

657.7229-2536.7

!!

0.8921

0.3054-2.1821

2123

1694-2706

2633

1071-4151

!!

4.8842

3.4039-7.1777

!!

4.7157

2.8324-12.2289
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TABLE 4: Descriptions and Estimates of Transmission Model Parameters
Model parameter definition
Demographic Parameters:
Population size

Symbol

Point Estimate (Value or Proportion)/ Point
Estimate
(Rate in months, if applicable)

Reference

N

981,750 people

[29]

Total Number of Children (15 years and
younger)
Total Number of Adults (15 years and
older)
Birth rate

Nc

434,886 people

[29]

Na

546,864 people

[29]

b

[29]

Death rate (children under 15)

dc

Death rate (adults 15 and over)

da

Aging rate
Disease Parameters:
Force of infection

α

45.5 births per 1000 people annually / 0.00325
per month; b80=0.8 b and b20=0.2 b
10.7 per 1000 population per year / 0.00140 per
month
6.4 per 1000 population per year / 0.00127 per
month
6.1% of children per year / 0.00335 per month

γ

Equation 1

Effective transmission rate in children
(low intensity infection)
Effective transmission rate in adults (low
intensity infection)
Effective transmission rate in children
(high intensity infection)
Effective transmission rate in adults
(high intensity infection)
Rate of recovery from infected state

βC80
βA80

!

∗ βC80 = 0.0082

βC20

!! ∗ βC80 = 0.0801

βA20

!! ∗ βA80 = 0.0387

ρ

[29]
[29]
Present
paper
Present
paper
Present
paper; [25]
Present
paper
Present
paper; [25]
Present
paper

0.0164
!

[29]

0.8338 x 10-3

TABLE 5: Time Series Prevalence Estimate Data for Hookworm Infection
Source Population

Year

Prevalence Estimate

N

Reference

Total Infected Children
Total Infected Children
Total Infected Adults
Total Infected Children
Total Infected Population

1998
2004
2005
2007
2009

73.3%
45.6%
32.3%
18.3%
32.2%

182
228
929
367
184

[41]
[21]
[42]
[43]
[20]
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TABLE 6: Description of Parameters and Variables for Full Intervention Model
Model parameter definition

Symbol

Estimate

Predicted
Distribution

Estimation
Method/
Reference

Six coverage terms sampled
through MCMC and based on
different treatment campaigns
15% (mebendazole)
72% (albendazole)

n/a

MCMC

Beta

[17]

εV1

Varied – 25%, 50%, 75%, 100%

Beta

εV2

Varied – 25%, 50%, 75%, 100%

Beta

ω

Varied – 1, 2, 3.5, 5 years

Exponential

pV

Varied – 25%, 50%, 75%, 100%
per month

n/a

MCMC;
[5]
MCMC;
[5]
MCMC;
[44]
MCMC

Treatment Parameters:
Chemotherapy treatment coverage

ν

Treatment efficacy rate

εT

Treatment Variables:
Vaccine efficacy rate in terms of
reducing force of infection
Vaccine efficacy rate in terms of
reducing progression to clinical disease
Vaccine waning rate
Vaccination coverage
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